Preeclampsia is one of the most common causes of maternal mortality in the developed world. Until today, it is still one of the most researched entities in obstetrics mainly because it increases the risk of gestational complications, life-long sequalae and increased maternal and neonatal morbidity. Therefore, all causes of hypertension and /or proteinuria need to be ruled out of our differential diagnosis to get a clear definition of preeclampsia and manage it appropriately. Our case describes a patient with hypertension and proteinuria that presented after the 20th week of gestation. In hospital management and close follow up was done with patient’s symptoms, blood pressure, laboratory values and proteinuria resolving during her gestation leading to a good obstetrical and neonatal outcome. It has never been reported in literature to have a resolving case of hypertension and proteinuria in a singleton gestation resulting in a healthy living neonate. Our findings raise a lot of questions about the pathophysiology of the disease and whether preeclampsia can normalize before the delivery of the placenta. Therefore, is it time we start thinking about the maternal cardiovascular origin of preeclampsia instead of the placental vascular origin. We definitely need bigger studies to ascertain these clinical findings.
Published in | Journal of Gynecology and Obstetrics (Volume 9, Issue 1) |
DOI | 10.11648/j.jgo.20210901.16 |
Page(s) | 26-30 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Preeclampsia, Hypertension, Gestation, Pregnancy, Proteinuria
[1] | Markham K., and Funai E. F.: Pregnancy-related hypertension. In Creasy R. K., Resnik R., and Iams J. D. (eds): Creasy and Resnik's maternal-fetal medicine, 7th edition. Philadephia: Elsevier, 2015. pp. 756-781. |
[2] | American College of Obstetricians and Gynecologists. 2013. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics and Gynecology 122: 1122–1131. |
[3] | Creanga A. A., Berg C. J., Syverson C., et al: Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015; 125: pp. 5-12. |
[4] | Peter von Dadelszen, Laura A. Magee & James M. Roberts (2003) Subclassification of Preeclampsia, Hypertension in Pregnancy, 22: 2, 143-148, DOI: 10.1081/PRG-120021060. |
[5] | Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia. Circulation Research, 124 (7), 1094–1112. doi: 10.1161/circresaha.118.313276. |
[6] | Pham, A., Rosenthal, E., Roman, A., Makhamreh, M., Berghella, V., Farhi, F., & Al-Kouatly, H. B. (2020). Preeclampsia resolution after fetal death in multifetal gestation: A systematic literature review. American Journal of Obstetrics and Gynecology, 222 (4), 385-389. doi: 10.1016/j.ajog.2019.10.097. |
[7] | (2013). Hypertension in Pregnancy. Obstetrics & Gynecology, 122 (5), 1122–1131. doi: 10.1097/01.AOG.0000437382.03963.88. |
[8] | Lisonkova S, Joseph KS. (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gyneco; 209: 544. e1-12. |
[9] | English, F. A., Kenny, L. C., & McCarthy, F. P. (2015). Risk factors and effective management of preeclampsia. Integrated blood pressure control, 8, 7–12. doi: 10.2147/IBPC.S50641 |
[10] | Lopez-Jaramillo, P., Barajas, J., Rueda-Quijano, S. M., Lopez-Lopez, C., & Felix, C. (2018). Obesity and Preeclampsia: Common Pathophysiological Mechanisms. Frontiers in Physiology, 9. doi: 10.3389/fphys.2018.01838. |
[11] | Rolnik D. L., Wright D., Poon L. C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. The New England Journal of Medicine. 2017; 377 (7): 613–622. doi: 10.1056/NEJMoa1704559. |
[12] | Rath, W., Faridi, A. & Dudenhausen, J. (2005). HELLP Syndrome. Journal of Perinatal Medicine, 28 (4), pp. 249-260. Retrieved 9 Dec. 2019, from doi: 10.1515/JPM.2000.033. |
[13] | Uzan, J., Carbonnel, M., Piconne, O., Asmar, R., & Ayoubi, J. M. (2011). Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular health and risk management, 7, 467–474. doi: 10.2147/VHRM.S20181. |
[14] | Airoldi, J. & Weinstein, L. (2007). Clinical Significance of Proteinuria in Pregnancy. Obstetrical & Gynecological Survey, 62 (2), 117-124. doi: 10.1097/01.ogx.0000253301.55009.ac. |
[15] | Sibai, B. (2021). Preeclampsia and Hypertensive Disorders. In M. Landon (Author), Gabbe's Obstetrics: Normal and Problem Pregnancies (7th ed., Vol. 38, pp. 708-750). Elsevier. |
[16] | Ekiz A, Kaya B, Polat I, et al. The outcome of pregnancy with new onset proteinuria without hypertension: retrospective observational study. J Matern Fetal Neonatal Med 2016; 29: 1765. |
[17] | Yamada T, Obata-Yasuoka M, Hamada H, et al. Isolated gestational proteinuria preceding the diagnosis of preeclampsia - an observational study. Acta Obstet Gynecol Scand 2016; 95: 1048. |
[18] | Podymow T., August P., Ayub Akbari A.: Management of Renal Disease in Pregnancy, Obstetrics and Gynecology Clinics, 2010-06-01, Volume 37, Issue 2, Pages 195-210. |
[19] | Damm J. A., Asbjornsdottir B., Callesen N. F., et al: Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care 2013; 36: pp. 3489-3494. |
[20] | Ramin S. M., Vidaeff A. C., Yeomans E. R., et al: Chronic renal disease in pregnancy. Obstet Gynecol 2006; 108: pp. 1531-1539. |
[21] | Arbel O et al: Hyperacute renal failure as the initial presentation of systemic lupus erythematosus. Lupus. 14 (4): 331-3, 2005. |
APA Style
Bersaoui Marianne, Halimeh Rawad, Msallem Mark, Chedid Julien, Feghali Joe. (2021). Normalization of Hypertension and Proteinuria in a Singleton Gestation; a Case Report and Literature Review. Journal of Gynecology and Obstetrics, 9(1), 26-30. https://doi.org/10.11648/j.jgo.20210901.16
ACS Style
Bersaoui Marianne; Halimeh Rawad; Msallem Mark; Chedid Julien; Feghali Joe. Normalization of Hypertension and Proteinuria in a Singleton Gestation; a Case Report and Literature Review. J. Gynecol. Obstet. 2021, 9(1), 26-30. doi: 10.11648/j.jgo.20210901.16
AMA Style
Bersaoui Marianne, Halimeh Rawad, Msallem Mark, Chedid Julien, Feghali Joe. Normalization of Hypertension and Proteinuria in a Singleton Gestation; a Case Report and Literature Review. J Gynecol Obstet. 2021;9(1):26-30. doi: 10.11648/j.jgo.20210901.16
@article{10.11648/j.jgo.20210901.16, author = {Bersaoui Marianne and Halimeh Rawad and Msallem Mark and Chedid Julien and Feghali Joe}, title = {Normalization of Hypertension and Proteinuria in a Singleton Gestation; a Case Report and Literature Review}, journal = {Journal of Gynecology and Obstetrics}, volume = {9}, number = {1}, pages = {26-30}, doi = {10.11648/j.jgo.20210901.16}, url = {https://doi.org/10.11648/j.jgo.20210901.16}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20210901.16}, abstract = {Preeclampsia is one of the most common causes of maternal mortality in the developed world. Until today, it is still one of the most researched entities in obstetrics mainly because it increases the risk of gestational complications, life-long sequalae and increased maternal and neonatal morbidity. Therefore, all causes of hypertension and /or proteinuria need to be ruled out of our differential diagnosis to get a clear definition of preeclampsia and manage it appropriately. Our case describes a patient with hypertension and proteinuria that presented after the 20th week of gestation. In hospital management and close follow up was done with patient’s symptoms, blood pressure, laboratory values and proteinuria resolving during her gestation leading to a good obstetrical and neonatal outcome. It has never been reported in literature to have a resolving case of hypertension and proteinuria in a singleton gestation resulting in a healthy living neonate. Our findings raise a lot of questions about the pathophysiology of the disease and whether preeclampsia can normalize before the delivery of the placenta. Therefore, is it time we start thinking about the maternal cardiovascular origin of preeclampsia instead of the placental vascular origin. We definitely need bigger studies to ascertain these clinical findings.}, year = {2021} }
TY - JOUR T1 - Normalization of Hypertension and Proteinuria in a Singleton Gestation; a Case Report and Literature Review AU - Bersaoui Marianne AU - Halimeh Rawad AU - Msallem Mark AU - Chedid Julien AU - Feghali Joe Y1 - 2021/02/27 PY - 2021 N1 - https://doi.org/10.11648/j.jgo.20210901.16 DO - 10.11648/j.jgo.20210901.16 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 26 EP - 30 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20210901.16 AB - Preeclampsia is one of the most common causes of maternal mortality in the developed world. Until today, it is still one of the most researched entities in obstetrics mainly because it increases the risk of gestational complications, life-long sequalae and increased maternal and neonatal morbidity. Therefore, all causes of hypertension and /or proteinuria need to be ruled out of our differential diagnosis to get a clear definition of preeclampsia and manage it appropriately. Our case describes a patient with hypertension and proteinuria that presented after the 20th week of gestation. In hospital management and close follow up was done with patient’s symptoms, blood pressure, laboratory values and proteinuria resolving during her gestation leading to a good obstetrical and neonatal outcome. It has never been reported in literature to have a resolving case of hypertension and proteinuria in a singleton gestation resulting in a healthy living neonate. Our findings raise a lot of questions about the pathophysiology of the disease and whether preeclampsia can normalize before the delivery of the placenta. Therefore, is it time we start thinking about the maternal cardiovascular origin of preeclampsia instead of the placental vascular origin. We definitely need bigger studies to ascertain these clinical findings. VL - 9 IS - 1 ER -